The Alzheimer’s Drug Discovery Foundation still expects new treatment options approved by 2025. (STAT Plus)

More reads

• The Alzheimer’s Drug Discovery Foundation still expects new treatment options approved by 2025. (STAT Plus)
• One-shot drug to end Sicilian curse comes at $1.8 million cost. (Bloomberg)
• First use of CRISPR against cancer in patients clears early safety hurdles. (Associated Press)
• Woodford’s woes cast a pall over British early biotech industry. (Bloomberg)